About Dr. Saleh A. Naser

We investigate the association of Mycobacterium avium subspecies paratuberculosis (MAP) with Crohn’s disease and Type I Diabetes based on molecular mimicry

The overall objective of our research program is to investigate the role of Mycobacterium avium subsp. paratuberculosis (MAP) in the etiology of Crohn’s disease and Type I Diabetes.

  1. Diagnosis: we developed nested PCR assay and have identified biomarkers to predict the presence of MAP in clinical samples.
  2. Pathogenesis: We are investigating MAP role in Crohn’s and Type I Diabetes in association with single nucleotide polymorphisms (SNPs) in disease-specific genes.
  3. Treatment: Our lab is the focal point in an international phase III clinical trial to treat Crohn’s patients with anti-MAP therapy.
  4. Funding: Our research program is currently funded from various sources.

 
Publications since 2014:
 

MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases.

OA Alrob, S Khatib, SA Naser. Journal of Physiology and Biochemistry, 1-8, 2016

A single capsule formulation of RHB-104 demonstrates higher anti-microbial growth potency for effective treatment of Crohn’s disease associated with Mycobacterium avium subspecies paratuberculosis
A Qasem, M Safavikhasraghi, SA Naser
Gut Pathogens 2016:8 (1), 45
RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn’s disease associated with Mycobacterium paratuberculosis
KP Alcedo, S Thanigachalam, SA Naser
Gut Pathogens 2016:8 (1), 32
Oxidative stress due to Mycobacterium avium subspecies paratuberculosis (MAP) infection upregulates selenium-dependent GPx activity
A Qasem, A Abdel-Aty, H Abu-Suwa, SA Naser
Gut pathogens 2016:8 (1), 1
Microbe detection via hybridizing magnetic relaxation nanosensors
S Naser, JM Perez, C Kaittanis (2015)
US Patent 9,109,249
Resolution of Crohn’s disease and complex regional pain syndrome following treatment of paratuberculosis
JT Kuenstner, W Chamberlin, SA Naser, MT Collins, CT Dow, JM Aitken, …
World J Gastroenterol 2015:21 (13), 4048-4062
Genetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn’s Disease
RC Sharp, M Abdulrahim, ES Naser, SA Naser
Frontiers in cellular and infection microbiology 2015:5
Domino effect of hypomagnesemia on the innate immunity of Crohn’s disease patients
SA Naser, A Abdelsalam, S Thanigachalam, AS Naser, K Alcedo
World journal of diabetes 2014:5 (4), 527
Pathophysiology of autism spectrum disorders: Revisiting gastrointestinal involvement and immune imbalance
M Samsam, R Ahangari, SA Naser
World J Gastroenterol 2014:20 (29), 9942-9951
Mycobacterium avium subspecies paratuberculosis causes Crohn’s disease in some inflammatory bowel disease patients
SA Naser, SR Sagramsingh, AS Naser, S Thanigachalam
World J Gastroenterol 2014:20 (23), 7403-7415
Bactericidal and Therapeutic Effects of Pure Non-Pasteurized Honey on Mycobacterium avium Subspecies Paratuberculosis
SA Naser, SM Elwasila, K Alcedo, II Riley
Austin J Biomed Eng 2014:1 (2), 1009
Demographic and Blood Lipid Profiles in Correlation with Heart Attacks among Mediterraneans
K Qabaha, WA Hassan, H Mansour, S Thanigachalam, S Naser
Journal of Nutrition & Food Sciences 2014:4 (4), 1

 

More publications:

https://scholar.google.com/citations?hl=en&user=nQ8rkisAAAAJ&view_op=list_works&sortby=pubdate